GC Cell (XKRX:144510) Other Long-Term Liabilities : ₩5,701 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GC Cell Other Long-Term Liabilities?

GC Cell's other long-term liabilities for the quarter that ended in Jun. 2024 was ₩5,701 Mil.

GC Cell's quarterly other long-term liabilities increased from Dec. 2023 (₩5,474 Mil) to Mar. 2024 (₩5,597 Mil) and increased from Mar. 2024 (₩5,597 Mil) to Jun. 2024 (₩5,701 Mil).

GC Cell's annual other long-term liabilities declined from Dec. 2021 (₩13,353 Mil) to Dec. 2022 (₩11,685 Mil) and declined from Dec. 2022 (₩11,685 Mil) to Dec. 2023 (₩5,474 Mil).

GC Cell Other Long-Term Liabilities Historical Data

The historical data trend for GC Cell's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell Other Long-Term Liabilities Chart

GC Cell Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

GC Cell Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

GC Cell Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

GC Cell Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of GC Cell's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

GC Cell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924

Website

https://www.gccell.com

GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell Headlines

No Headlines